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Abstract
We previously developed an in vivo site-specific transfection method using a suction device
in mice; namely, a tissue suction-mediated transfection method (tissue suction method).
The aim of this study was to apply the tissue suction method for cardiac gene transfer.
Naked plasmid DNA (pDNA) was intravenously injected in mice, followed by direct suction
on the beating heart by using a suction device made of polydimethylsiloxane. We first exam-
ined the effects of suction conditions on transgene expression and toxicity. Subsequently,
we analyzed transgene-expressing cells and the transfected region of the heart. We found
that heart suction induced transgene expression, and that −75 kPa and −90 kPa of suction
achieved high transgene expression. In addition, the inner diameter of the suction device
was correlated with transgene expression, but the pressure hold time did not change trans-
gene expression. Although the tissue suction method at −75 kPa induced a transient
increase in the serum cardiac toxicity markers at 6 h after transfection, these markers
returned to normal at 24 h. The cardiac damage was also analyzed through the measure-
ment of hypertrophic gene expression, but no significant differences were found. In addition,
the cardiac function monitored by echocardiography remained normal at 11 days after trans-
fection. Immunohistochemical analysis revealed that CD31-positive endothelial cells co-
expressed the ZsGreen1-N1 reporter gene. In conclusion, the tissue suction method can
achieve an efficient and safe gene transfer to the beating heart in mice.
Introduction
Although there have been many efforts to develop pharmacological drugs and surgical devices
to combat heart failure, it remains the major cause of death and hospitalization [1]. It is
reported that more than 23 million people in the world have heart failure-related diseases. In
the past two decades, our knowledge of the molecular pathways associated with heart failure
have increased, indicating potential targets for the cure of cardiac disorders [2–4]. As it is diffi-
cult to control these signaling pathways by using pharmacological reagents such as small
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molecule inhibitors, gene therapy has emerged as a possible strategy against heart failure [3, 4].
However, many issues need to be resolved, including transfection efficiency, tissue specificity,
toxicity, and immune activity. For example, gene transfer techniques using viral vectors can
achieve high transfection efficiency, but often result in off-target gene expression in unin-
tended tissues, such as the liver [5]. In contrast, non-viral vectors such as plasmid DNA
(pDNA) have limited immunogenicity, but achieve low transfection efficiency [3, 4]. These
problems may affect the clinical outcomes and preclinical results. Thus, organ-specific and
safe gene delivery systems are needed for both clinical and experimental use.
Previously, we developed a tissue suction-mediated transfection method (tissue suction
method) [6–8]. This is a simple gene delivery method: naked nucleic acids, such as pDNA and
siRNA, are injected intravenously, followed by the application of suction pressure on the target
organ. Previously, we have demonstrated that this tissue suction method of gene transfer can
be applied for transfection of the liver, kidney, heart, and spleen of mice [6]. Moreover, this
transfection technique did not cause severe damage when applied to the liver [6, 7] and kidney
[8] of mice. Hence, a cardiac suction method should offer a promising approach for the pro-
gression of gene functional analysis and clinical gene therapies. The parameters related to the
transfection efficiency and toxicity should be optimized to establish a reproducible transfection
method. In addition, it is essential to understand the transfected cell types to select suitable
genes for the treatment of cardiac dysfunction. However, there have been few studies of the
effect of the physical stimuli by suction on the heart.
In the present study, we examined the effect of suction conditions on cardiac transfection
using a computer-regulated tissue suction device [7, 8]. Then, the possible cardiac damage
induced by suction was investigated through the measurement of hypertrophic gene expres-
sion, serum cardiac toxicity markers, and echocardiographic parameters. Moreover, we identi-
fied the transfected cell types by using immunostaining.
Materials and methods
Fabrication of tissue suction device
Three types of suction devices were fabricated, as reported previously [6] (Table 1). Briefly,
precured polydimethylsiloxane (10:1) solution was incubated in the molds at 75˚C for 12 h.
Thereafter, the cured polydimethylsiloxane was formed into individual devices. Individual
devices were linked to a silicone tube with an outer diameter of 2 mm. The tube was used to
supply the negative pressure. The device height was 3 mm. The inner and outer diameters of
the device were designed as indicated in Table 1. Unless otherwise noted, device I was used in
the experiments.
Suction pressure-controlled computer system
The suction pressure-controlled computer system was constructed as described previously [7].
Briefly, a vacuum pump generated negative pressure, controlled by a PC with LabVIEW soft-
ware (National Instrument, Austin, TX) via an electropneumatic regulator (ITV0090; SMC,
Table 1. Suction devices.
Device type Inner diameter Outer diameter
I 1.5 mm 3 mm
II 2 mm 3 mm
III 3 mm 5 mm
https://doi.org/10.1371/journal.pone.0228203.t001
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Tokyo, Japan). The actual suction pressure was detected by using a pressure sensor (Sensez,
Tokyo, Japan), and saved in the PC.
pDNA and mice
The pCMV-Luciferase (pCMV-Luc) used was as constructed previously [9]. pZsGreen1-N1
was purchased from Clontech (Takara Bio, Shiga, Japan). The Escherichia coli strain DH5a was
used for amplifying pDNA. The quality of pDNA was examined by measuring the ratio of
absorbance at 280 nm to that at 260 nm. Five-week-old female ICR mice were purchased from
Japan SLC (Shizuoka, Japan). All animal experiments were conducted in accordance with the
Guide for the Care and Use of Laboratory Animals, as adopted and promulgated by the United
States National Institutes of Health (Bethesda, MD). The study protocol permission numbers
2013–41, 2014–32, and 2014–56 were approved by the Animal Research Committee, Kyoto
University, Japan, and 1812251497–2 was approved by the Institutional Animal Care and Use
Committee of Nagasaki University, Japan.
In vivo transfection by the tissue suction method
The mice were anesthetized with isoflurane or three types of mixed anesthetic agents (0.75 mg/
kg medetomidine, 4.0 mg/kg midazolam, and 5.0 mg/kg butorphanol) and their respiration
was maintained artificially at 1 cm3 and 100 rpm by using a ventilator (SN-480-7; Sinano-Sei-
sakusho, Tokyo, Japan) after tracheal intubation. When anesthesia and respiration were con-
trolled, the left chest costal between the third rib and fourth rib was cut to give minimal
exposure of the left ventricle. Mice were intravenously injected with 200 μL of saline contain-
ing 100 μg pDNA, and the ventricle was suctioned immediately by a pressure-controlled suc-
tion device. At the end of the surgery, the chest was closed by using suture threads. Sham-
operated mice underwent the same procedure, without suction. At the end of studies, all mice
were sacrificed by cervical dislocation, or blood removal from vena cava under anesthesia.
Luciferase assay
Luciferase assays was performed as previously described [9]. The mice heart and the other
organs were dissected 6 h after transfection. The organs were stored at −80˚C before each
assay was performed. The luciferase activities of the organ lysate were determined by using a
PicaGene Luminescent Kit (Toyo Ink, Tokyo, Japan) and luminometer (Lumat LB 9507;
EG&G Berthold, Bad Wildbad, Germany). Each luciferase activity measurement was normal-
ized to protein content, which was determined by using a Protein Quantification Kit (Dojindo
Molecular Technologies, Tokyo, Japan).
Quantitative real-time RT-PCR
Hypertrophic genes, α-myosin heavy chain (MyHC), β-MyHC, SERCA, atrial natriuretic factor
(ANF), and B-type natriuretic peptide (BNP) were measured by using real-time RT-PCR. At 48
h after transfection, the heart was dissected and minced by scissors to pieces smaller than 5
mm. Total mRNA was extracted from the minced organ by using RNeasy Fibrous Tissue Mini
Kit (74704; Qiagen, Hilden, Germany). Thereafter, reverse transcription of mRNA and real-
time PCR using SYBR Premix Ex Taq (RR039A; Takara Bio) was performed as described pre-
viously [10]. The sequences of primers used in the present study are shown in Table 2.
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Evaluation of creatine kinase-muscle/brain (CK-MB) and troponin T2
(TNNT2)
Six or twenty-hour after transfection, the mice were anesthetized, and blood samples were col-
lected from the abdominal vena cava of each mouse. The collected samples were left overnight
at 4˚C, and centrifuged at 3,000×g for 15 min at 4˚C to obtain the serum from the supernatant.
Separated serum was stored at −80˚C before the assays were performed. Creatine kinase-mus-
cle/brain (CK-MB) and troponin T2 (TNNT2) levels in the serum were determined by using a
commercial enzyme-linked immunosorbent assay kit (Wuhan USCN Business, Houston,
Texas, USA) in accordance with the recommended procedures.
Hematoxylin and eosin staining
Twenty four-hour after transfection, mice were sacrificed, and the hearts were removed. Col-
lected mouse tissues were fixed in 4% phosphate-buffered paraformaldehyde and embedded in
paraffin. The samples were sliced into 5 μm sections, the paraffin was removed by application
in xylene, and the slices were rehydrated in graded alcohol series. The sections were then
stained with hematoxylin and eosin (HE). The histology of the heart sections was examined by
using a microscope (BZ-X700; Keyence, Osaka, Japan).
Echocardiographic analysis
Echocardiography was performed at 11 days after transfection as previously described [11]
using a Toshiba PowerVision 8000 (Toshiba, Tokyo, Japan) equipped with a 12 MHz imaging
transducer.
Immunohistochemistry
The heart was dissected at 24 h after transfection of pZsGreen1-N1. The frozen sections of the
heart were prepared and fixed with acetone for 10 min. Non-specific binding to the sections
was blocked by incubation in 5% normal goat serum (G9023, Sigma Aldrich, St. Louis, Mis-
souri, USA) for 30 min at room temperature. Thereafter, the samples were incubated with pri-
mary antibodies against CD31 (1:100 dilution, #102401; BioLegend, San Diego, CA, USA) and
α-sarcomeric actin (1:100 dilution, ab68167; Abcam, Boston, MA, USA) overnight at 4˚C. The
samples were then washed with PBS, and reacted with the following secondary antibodies for 1
h at room temperature (1–30˚C): Alexa Fluor 647-conjugated antibody against rat IgG (1:200
dilution, 112-605-167; Jackson Immuno Research Laboratories, West Grove, PA); Alexa Fluor
555-conjugated antibody against rabbit IgG (1:500 dilution, #4413; Cell Signaling Technology,
Danvers, MA). The stained sections were observed by using confocal laser scanning micros-
copy (CLSM).
Table 2. Primer sequences used for quantitative real time RT PCR.
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Statistical analysis
Statistical significance was determined by analysis of variance (ANOVA) for multiple compari-
sons among different groups, followed by the Tukey-Kramer test. For the comparisons
between two independent groups, unpaired t-tests were used. All P values were two-tailed, and
values of P< 0.05 were considered to indicate statistical significance.
Results
Evaluation of the effects of suction conditions on transgene expression
Effects of varying suction pressure. Previously, we developed a suction pressure control
system [7, 8]. Our system can regulate the minimum magnitude of the suction pressure and
waveform, which comprises pressure supply time, pressure hold time, and pressure release
time. First, the pressure supply time, hold time, and release time were set to 1 s, 3 s, and 1 s,
respectively, and various negative pressures were applied to the heart. Although there was no
significant difference, when the tissue suction was set to −75 kPa and −90 kPa, higher trans-
gene expression tended to be induced in the heart (Fig 1A). Unless otherwise noted, the suc-
tion pressure was set to −75 kPa in the subsequent studies.
Effects of suction device size. Next, the transfection was performed by using three differ-
ent sizes of the device (Table 1). In this experiment, pressure supply time, hold time, and
release time were set to 1 s, 3 s, and 1 s, respectively, and the minimum pressure was set to −75
kPa. Tissue suction using device III induced the highest transgene expression (Fig 1B). How-
ever, the larger sized suction device would have a greater impact on the near organs. Since we
would like to focus on the direct effects on the heart function, we used device I having mini-
mum diameter in the subsequent experiments.
Effects of pressure hold time. To minimize the duration of suction, the effect of pressure
hold time on the transgene expression was investigated (Fig 1C). Pressure hold time was varied
from 0 s to 3 s when the negative pressure condition was set to −75 kPa and the pressure supply
time and release time were set to 1 s. There were no significant differences in the transgene
expression when 0 s, 1 s, and 3 s were used for the pressure hold time (Fig 1C). In the following
studies, pressure hold time was set to 1 s to obtain reproducible results.
Evaluation of the possibility of cardiac injury induced by tissue suction
Changes in hypertrophic gene expression and serum cardiac toxicity markers. Acute
cardiac damage, such as myocardial infarction, has been reported to affect hypertrophic gene
expression [12]. For this reason, the hypertrophic gene expression levels of αMyHC, βMyHC,
Serca, ANF, and BNP were analyzed 48 h after tissue suction (Fig 2). In this experiment, the
pressure degree was varied from set to −15, −30 and −75 kPa. As a result, these hypertrophic
genes were hardly affected by tissue suction (Fig 2). Consequently, the two types of serum car-
diac toxicity markers, CK-MB and TNNT2, were evaluated followed by a suction set to −75
kPa. Although both serum cardiac injury markers significantly elevated compared to sham
group at 6 h after transfection, both reversed normal levels at 24 h (Fig 3).
Histological analysis of tissue sections. Tissue sections of the suctioned heart were
stained with HE to reveal histological abnormalities. Suction at −75 kPa did not induce histo-
logical abnormalities at 24 h after transfection (Fig 4).
Electrocardiographic analysis. Severe cardiac damage, such as myocardial infarction, has
been reported to impair cardiac function after 1 week [13]. For this reason, we performed
echocardiography at 11 days after transfection to evaluate the effect of tissue suction on cardiac
Tissue suction-mediated gene transfer to the beating heart in mice
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function. There were no significant differences between the groups transfected by cardiac suc-
tion and the sham-operated group (Table 3).
Distribution of transgene expression
Selective gene transfer to the heart. To evaluate the organ selectivity of the transgene
expression, luciferase expression in the heart, right and left lungs, liver, spleen, and kidneys
were analyzed at 6 h after transfection. As shown in Fig 5A, the transgene expression was
mainly observed in the suctioned heart and partially at the left lung, up to 23% compared with
the heart.
Identification of transgene-expressing cells. To clarify the transfected cell types, immu-
nohistochemical analysis was performed 24 h after transfection of the ZsGreen1-N1 gene. Car-
diomyocytes and vascular endothelial cells were stained with an anti α-sarcomeric actin
antibody and an anti-CD31 antibody, respectively. ZsGreen1-N1 expression was mainly co-
localized with CD31-positive endothelial cells (Fig 5B).
Discussion
The body of knowledge on cardiac regeneration and healing pathways has rapidly evolved
recently, and reliable methods are needed to verify the therapeutic targets in experimental and
clinical studies. Several cardiac gene transfer techniques have been developed. They are
broadly divided into viral and non-viral vector-based methods [3]. Viral vectors such as
adeno-associated virus (AAV) is often used to transduce therapeutic gene to the heart because
of the long-term expression [3, 4]. AAV has a heart selectivity for gene transfection after intra-
venous administration [5, 14]. Naked non-viral vectors are relatively safe in terms of the
immune responses; however, they generally result in poor transgene expression. To overcome
these problems, many innovative approaches have been developed. The ultrasound-mediated
transfection method has been applied to improve the transfection efficiency of non-viral
Fig 1. The effect of pressure conditions on transgene expression in the heart. a, Luciferase expression in the heart induced by various degrees of suction pressure. The
heart was suctioned at −30, −45, −60, −75, and −85 kPa following intravenous injection of pCMV-Luc solution (100 μg/200 μL/head). b, Luciferase expression in the
heart induced by tissue suction with devices with different inner diameters. Suction devices I, II, and III were used for cardiac transfection. c, Luciferase expression in
the heart was induced by tissue suction with various pressure hold times. The heart was suctioned at −75 kPa with pressure holding times of 0, 1, and 3 s. Each item
represents the pressure supply-hold-release time. a–c, The transgene expression was determined by luciferase assay at 6 h after transfection. Open columns and open
dots represent the mean and individual data, respectively (n = 3).
https://doi.org/10.1371/journal.pone.0228203.g001
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vectors for the treatment of heart failure in the rodent model [15, 16]. Therefore, we hypothe-
sized that heart selective and enhanced gene expression by naked pDNA would be achieved by
the application of the tissue suction method to the beating heart of mice. The simple procedure
of the tissue suction method may have an advantage in clinical and preclinical studies. In the
present study, we applied the tissue suction method to cardiac gene delivery and this is the first
report to clarify the characteristics of the tissue suction-mediated gene transfer in the beating
heart in mice. The optimal transgene expression was obtained by using a pressure controlled-
suction device set at −75 kPa and this application of optimal suction to the beating heart did
not induce severe cardiac injury. Transgene expression induced by tissue suction method
reached approximately 10 pg/mg protein in the mouse heart. Fujii H, et al, demonstrated that
4 pg /mg protein of stem cell growth factor protein improved cardiac function in the rodent
model [15, 16]. Although the kinetics of transfected protein should be further investigated,
transfection efficiency of tissue suction method would be applicable for the treatment of heart
disease. We also found that the tissue suction method could target the endothelial cells of the
cardiac capillaries.
Fig 2. The effect of tissue suction on the cardiac function-related gene expressions. The expression of cardiac function-related genes of the heart after tissue suction.
The hearts were dissected at 48 h after transfection. α-MyHC, β-MyHC, SERCA, ANF, and BNP expression in whole heart tissue was determined by real-time PCR. Open
columns and open dots represent the mean and individual data, respectively (n = 3–4). ns: not significant.
https://doi.org/10.1371/journal.pone.0228203.g002
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The expression of cardiac hypertrophy-related genes, α-MyHC, β-MyHC, SERCA, ANF,
and BNP, was not affected by the characteristics of the tissue suction method (Fig 2). We also
evaluated the serum levels of two cardiac toxicity markers, TNNT2 and CK-MB. CK-MB is a
cardiac specific enzyme present in the myocardial cytoplasm, and TNNT2 is also a cardiac-
specific protein mostly binding to the myofibrils and partially existing in the cytoplasm freely
[17]. These protein markers are released from the injured myocardium and can be used as
indicators of myocardial tissue damage. Although heart suction induced levels of circulating
CK-MB and TNNT2 levels at 6 h, the levels were restored to normal at 24 h (Fig 3). Moreover,
HE sections and echocardiography revealed that the tissue suction method did not induce
severe damage in the heart in terms of cardiac morphology and functions (Fig 4, Table 3).
Ultrasound-mediated gene transfer to the heart that can form in pores in the cellular mem-
branes also caused a troponin I transient peak [16]. Although the mechanism of the tissue suc-
tion method has not been fully clarified, the holes are expected to be transiently formed on the
cell membranes because the tissue suction method can transfer pDNA into the suctioned site.
Therefore, the transient peaks of the component myocardial proteins in the serum may reflect
the holes in the membranes of cardiomyocytes induced by physical stimuli. In summary, the
present study demonstrate that tissue suction method did not induce severe dysfunction in the
mouse heart. Unfortunately, we did not take electro-cardiogram. The possibility of arrhyth-
mias induced by tissue suction method should be investigated in the future, especially in the
context of application on the clinical settings.
To identify the transfected cell types, we performed immunohistochemical analysis after
the transfection of ZsGreen1-N1. In the heart transfected by the suction method, transgene
expression was observed in the CD31-positive endothelial cells but not in cardiomyocytes (Fig
5B); however, when the suction method was applied to the kidney, transgene expression was
observed in the pericytes but not in the endothelial cells of the kidney [10]. The penetration of
macromolecules is prevented by a vascular wall composed of tight junctions, adhesion
Fig 3. The effect of tissue suction on the serum cardiac toxicity markers. The serum levels of cardiac toxicity markers at 6 and 24 h after pDNA transfection. Serum
TNNT2 and CK-MB levels of sham group were measured at 24 h post operation. Serum TNNT2 and CK-MB were determined by using commercially available ELISA
kits. Open columns and open dots represent the mean and individual data, respectively (n = 3–4). ��p<0.01 compared with all other groups.
https://doi.org/10.1371/journal.pone.0228203.g003
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junctions, and basement membranes [18, 19]. One of the major differences between the kid-
neys and the heart lies in the endothelial structure. The microvascular endothelium of the kid-
neys, peritubular capillaries, and glomerular capillaries is fenestrated and transports materials
[20]. In contrast, continuous capillaries are found in the heart endothelium [21]. Moreover, it
was reported that hydrodynamic injection enlarged endothelium fenestrate, which resulted in
gene transfer to hepatocytes [22–24]. Consequently, pDNA may pass through the fenestration
in the liver and kidneys, but could not penetrate the blood vessels in the heart because of the
continuous nature of the endothelial cells. However, there is little information about the effect
of tissue suction on pDNA distribution. A hypothesis about the conditions of a cell membrane
and the distribution of pDNA is needed for future analysis.
Fig 4. Histological assessment of HE stained cardiac sections. The hearts were dissected at 24 h after transfection. Five micrometer thick sections were stained with
HE. a, Normal mouse heart. b, Sham operated mouse heart. c, Suctioned heart (−75 kPa). Scale bars = 100 μm.
https://doi.org/10.1371/journal.pone.0228203.g004
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The present study focused on the characterization of the tissue suction method. Two-
dimensional analysis revealed that the tissue suction method could target endothelial cells in
the heart tissue (Fig 5B). Deng et al. have demonstrated that intercellular-adhesion-molecule-
1-targeted microbubbles had successfully delivered the angiopoetin-1 gene to inflammatory
endothelial cells and improved cardiac function of mice with myocardial infarction [25]. More
recently, Hao et al. reported that CXCR7, which is a chemokine receptor for CXCL12, was a
key regulator for angiogenesis in the endothelium [26]. The information about transfected
cells may be of value for future studies of the relationship between the therapeutic gene expres-
sion and their pharmacological effects.
For safe gene therapy, expression of a therapeutic gene should be localized in the target
organ. We previously reported that kidney or liver suction achieved suction site-specific trans-
gene expression [6, 8]. However, in the case of cardiac transfection, the tissue suction method
induced the transgene expression not only in the heart, but also partially in the left lung (Fig
5A). In general, the availability of the naked pDNA to lung cells is very low after intravenous
administration [6]. Consistent with the past observations, transgene expression was not
observed in the right lung. When these were taken into consideration, we speculated that tissue
deformation induced by the device application resulted in gene expression in the left lung. We
demonstrated that the larger device was more effective for gene transfection (Fig 1B) because
of its large suctioned area. It would there be important to optimize the size of the suction
device for each animal to obtain selective and efficient gene transfer to the heart.
Functional RNA molecules, such as micro RNA, small interfering RNA (siRNA), and anti-
sense oligonucleotides, are a promising research tool in functional genomics, and are consid-
ered as therapeutic pharmaceuticals [27, 28]. In the present study, we showed that transgene
expression might be occurred in the endothelial cells of the mouse heart (Fig 5). We have pre-
viously reported a tissue suction method that could deliver siRNA to the mouse liver [6].
Although further studies about the transfection efficiency and the ratio and types of the deliv-
ered cells is needed, the tissue suction method may be useful for the analysis of a gene function
using oligonucleotides in the mouse heart and may be adaptable to the clinical therapy of heart
diseases by oligonucleotide-based drugs.
In the present study, we have investigated the transgene expression only at 6 hr after trans-
fection because the aim of this study is to evaluate the effect of transfection parameter on a
transfection efficiency and cardiac functions. In a translational research, the kinetics of a trans-
fected protein should be analyzed. We and other group have previously reported that pDNA
Table 3. Echocardiographic analysis at 11 days after transfection.
Sham (n = 3) Suction (n = 3) p value
LVDd (mm) 2.1 ± 0.1 2.0 ± 0.1 0.27
LVDs (mm) 0.9 ± 0.1 0.8 ± 0.1 0.57
FS (%) 54 ± 5.5 59 ± 2.5 0.46
EF (%) 90 ± 3.8 93 ± 1.3 0.50
IVS (mm) 0.8 ± 0.03 0.8 ± 0.00 0.42
PW (mm) 0.8 ± 0.06 0.9 ± 0.06 0.29
HR (/min) 680 ± 18 684 ± 12 0.84
Values are presented as the mean ± SEM (n = 3). LVDd, left ventricular end diastolic dimension; LVDs, left
ventricular end systolic dimension; FS, fractional shortening; EF, ejection fraction; IVS, interventricular septal
thickness; PW, posterior wall thickness; HR, heart rate. Unpaired t-tests were used for the comparisons between two
groups.
https://doi.org/10.1371/journal.pone.0228203.t003
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Fig 5. Distribution of transgene expression and identification of transfected cell types. a, Selective gene transfer to the heart by the
tissue suction method. The heart was suctioned at −75 kPa. At 6 h after transfection, various tissues (the heart, left and right lungs,
liver, spleen, and kidneys) were collected. Transgene expression in each organ was determined by luciferase assay and normalized to
the expression of cardiac tissue. Open columns and open dots represent the mean and individual data, respectively (n = 3).
���p<0.001 compared with all other groups. b, Analysis of transgene-expressing cell types by immunostaining of endothelial cells and
cardiac muscle cell markers. The pZsGreen1-N1 was transfected to the heart by the tissue suction method. The heart was suctioned at
−75 kPa and then collected at 24 h after transfection. Finally, 10 μm-thick frozen sections were stained with anti-CD31 and α-
sarcomeric actin antibodies and DAPI. The stained sections were observed by using CLSM. Magnification ×40. Blue: nucleus; yellow:
ZsGreen1-N; cyan: α-sarcomeric actin-positive cardiac muscle cells; magenta: CD31-positive endothelial cells. Scale bars = 50 μm.
White arrows indicate ZsGreen1-expressing cells.
https://doi.org/10.1371/journal.pone.0228203.g005
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removed CG motif (CpG free pDNA) could be used for sustained gene expression [10, 29–30].
We would like to evaluate the kinetics of a therapeutic protein in the future study using CpG
free pDNA. In conclusion, the present study showed the characteristics of transfection by the
tissue suction method to the beating heart of the mouse. We demonstrated that tissue suction
by the pressure-controlled device was a safe, reproducible, and feasible transfection technique.
The polydimethylsiloxane (PDMS)-based suction device used in the present study can be
mounted on a microscopy [31]. Recently, minimally invasive thoracic surgery techniques have
been developed [32]. Although there are several obstacles to be overcome, such as basic studies
on animal models and bridging studies from animals to humans, the tissue suction method
may provide an option for the treatment of heart failure in clinical settings in combination
with novel surgery techniques.
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